-
-based genome editing tools into next-generation gene therapies to treat those untreatable human genetic diseases, such as cystic fibrosis and liver cancer. To achieve this, we will engineer advanced
-
cancer patients. The lab employs cutting-edge technologies (immunopeptidomics, T cell engineering, single-cell transcriptomics, spatial transcriptomics, CRISPR technologies) paired with in vivo animal
-
join our team in developing innovative CAR-T cell therapies for colorectal cancer. Our lab focuses on engineering immune cells with greater precision, persistence, and safety, using synthetic biology
-
, Cell Biology, Biochemistry Physics, (Electrical) Engineering, Statistics, Computer Science or a related field. Description: This is a full-time postdoctoral fellow position in a neurobiology laboratory
-
discovery to inventing biomedical devices and technology and creating innovative ways to treat patients in the NIH Clinical Center. As a postdoc in CCR, you’ll have opportunities to: Collaborate with and
-
preferred. Background with pharmacology, cell therapy or antibody engineering is also desired. · Previous experience in working with animal models of human cancers is preferred. · Literature
-
the homeostasis of uridine and its role in metabolism, which provides a new angle for understanding the pathophysiology of obesity, diabetes and cancer. Work in the lab utilizes both genetically engineered mouse
-
/computer science/engineering without biology backgrounds but who want to pivot to a future career in biomedical sciences are strongly encouraged to apply. The candidate must have at least 2 years of experience with
-
gene editing, single cell RNA sequencing, bioinformatics, genetic engineering in mice, intravital microscopy and other imaging modalities, and a number of cell and molecular techniques. For more
-
The Rowland Institute at Harvard seeks outstanding early-career experimentalists in all fields of science and engineering to establish fully independent research groups in the rich intellectual